China Operating Income vs Ebitda Analysis
CJJD Stock | USD 1.87 0.13 6.50% |
China Jo financial indicator trend analysis is way more than just evaluating China Jo Jo prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China Jo Jo is a good investment. Please check the relationship between China Jo Operating Income and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Operating Income vs Ebitda
Operating Income vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China Jo Jo Operating Income account and Ebitda. At this time, the significance of the direction appears to have very strong relationship.
The correlation between China Jo's Operating Income and Ebitda is 0.87. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Ebitda in the same time period over historical financial statements of China Jo Jo Drugstores, assuming nothing else is changed. The correlation between historical values of China Jo's Operating Income and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of China Jo Jo Drugstores are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Operating Income i.e., China Jo's Operating Income and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.87 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Operating Income
Operating Income is the amount of profit realized from China Jo Jo operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of China Jo Jo Drugstores is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Ebitda
Most indicators from China Jo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China Jo Jo current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. At present, China Jo's Discontinued Operations is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 3.8 M, whereas Enterprise Value Over EBITDA is forecasted to decline to (21.86).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.3M | 718.0K | 5.4M | 5.7M | Income Tax Expense | 1.1M | 394.5K | 62.9K | 59.7K |
China Jo fundamental ratios Correlations
Click cells to compare fundamentals
China Jo Account Relationship Matchups
High Positive Relationship
High Negative Relationship
China Jo fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 99.5M | 106.3M | 106.4M | 91.0M | 95.1M | 67.2M | |
Total Stockholder Equity | 20.6M | 25.7M | 24.1M | 18.0M | 15.6M | 22.5M | |
Net Debt | 38.3M | 24.7M | 30.2M | 23.3M | 23.1M | 24.2M | |
Retained Earnings | (36.4M) | (44.9M) | (48.1M) | (69.3M) | (73.5M) | (69.8M) | |
Cash | 16.2M | 22.0M | 18.5M | 18.8M | 20.1M | 10.3M | |
Cash And Short Term Investments | 16.3M | 22.1M | 18.6M | 18.8M | 20.1M | 10.5M | |
Common Stock Shares Outstanding | 136.7K | 169.9K | 14.5K | 509.8K | 1.4M | 1.1M | |
Liabilities And Stockholders Equity | 99.5M | 106.3M | 106.4M | 91.0M | 95.1M | 67.2M | |
Other Stockholder Equity | 44.9M | 54.2M | 66.5M | 84.0M | 86.4M | 90.7M | |
Total Liab | 80.7M | 81.9M | 83.6M | 74.3M | 80.8M | 45.3M | |
Total Current Assets | 61.0M | 72.2M | 75.5M | 64.5M | 69.7M | 47.9M | |
Total Current Liabilities | 57.4M | 64.9M | 74.4M | 66.5M | 74.4M | 46.4M | |
Accounts Payable | 21.6M | 29.9M | 27.3M | 27.0M | 31.6M | 19.7M | |
Net Receivables | 14.9M | 18.5M | 22.5M | 16.8M | 19.1M | 13.1M | |
Non Current Liabilities Total | 23.3M | 17.0M | 9.2M | 7.8M | 6.4M | 4.9M | |
Short Long Term Debt Total | 54.5M | 46.8M | 48.7M | 42.2M | 43.2M | 25.8M | |
Other Current Liab | 3.9M | 7.3M | 1.6M | 4.8M | 4.2M | 4.8M | |
Property Plant And Equipment Net | 29.3M | 23.3M | 19.7M | 19.0M | 18.7M | 14.7M | |
Non Current Assets Total | 38.5M | 34.1M | 30.9M | 26.5M | 25.4M | 23.2M | |
Non Currrent Assets Other | 794.6K | 1.7M | 3.3M | 1.5M | 1.8M | 2.4M | |
Other Assets | 2.3M | 2.5M | 3.3M | 2.5M | 2.2M | 2.7M | |
Short Term Investments | 157.2K | 91.5K | 94.6K | (12.7M) | (11.5M) | (10.9M) | |
Inventory | 12.2M | 17.0M | 16.0M | 15.3M | 17.2M | 12.4M | |
Other Current Assets | 163.6K | 14.6M | 1.5M | 13.5M | 13.3M | 13.1M | |
Property Plant And Equipment Gross | 29.3M | 23.3M | 19.7M | 19.0M | 30.8M | 15.6M | |
Accumulated Other Comprehensive Income | 2.7M | 4.1M | 5.7M | 3.0M | 2.3M | 3.8M | |
Short Term Debt | 31.3M | 29.8M | 42.8M | 34.4M | 37.1M | 21.4M | |
Property Plant Equipment | 8.4M | 7.4M | 19.7M | 19.0M | 21.9M | 23.0M | |
Current Deferred Revenue | 708.1K | 1.1M | 1.9M | 695.9K | 518.2K | 492.3K | |
Intangible Assets | 4.4M | 4.3M | 4.3M | 3.9M | 3.6M | 3.8M | |
Net Tangible Assets | 17.2M | 22.2M | 20.5M | 14.8M | 13.3M | 17.6M | |
Retained Earnings Total Equity | (29.7M) | (30.6M) | (36.4M) | (44.9M) | (40.4M) | (38.4M) | |
Capital Surpluse | 43.6M | 44.9M | 54.2M | 66.5M | 76.5M | 80.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.93) | Revenue Per Share 107.003 | Quarterly Revenue Growth (0) | Return On Assets (0.02) | Return On Equity (0.27) |
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.